BUB1B-PAK6: A Readthrough Fusion Gene with Potential Kinase and Mitotic Checkpoint Functions
A naturally occurring readthrough transcript combining BUB1B and PAK6, implicated in cell cycle regulation and cancer biology.
Gene Information Card
| Symbol | BUB1B-PAK6 |
|---|---|
| Full Name | BUB1B-PAK6 readthrough (NMD candidate) |
| Gene Type | Readthrough (fusion) gene |
| Chromosomal Location | Chromosome 15 (15q15.1) – based on BUB1B and PAK6 locations |
| NCBI Gene ID | 100529197 ncbi.nlm.nih.gov/gene/100529197 |
| Ensembl ID | ENSG00000259363 |
| UniProt ID | Not applicable (no protein product; NMD candidate) |
| OMIM ID | Not assigned |
| HGNC ID | HGNC:40081 |
| Aliases | BUB1B-PAK6 readthrough transcript |
Description
BUB1B-PAK6 is a naturally occurring readthrough gene located on chromosome 15, formed by the transcriptional fusion of the BUB1B (BUB1 mitotic checkpoint serine/threonine kinase B) and PAK6 (p21 (RAC1) activated kinase 6) genes. This readthrough transcript is classified as an NMD (nonsense-mediated decay) candidate, suggesting it may be targeted for degradation and not produce a stable protein. However, its existence has been annotated in major genomic databases, and it may play regulatory roles in gene expression or contribute to cellular diversity under certain conditions. The fusion combines sequences from BUB1B, involved in mitotic spindle checkpoint, and PAK6, a kinase implicated in androgen receptor signaling and cell motility, potentially linking cell cycle control with signaling pathways.
Disease Associations
| Disease category | Pathophysiological mechanism | Genomic evidence |
|---|---|---|
| Cancer (general) | Potential dysregulation of mitotic checkpoint and kinase signaling due to altered BUB1B/PAK6 expression; readthrough may produce aberrant transcripts affecting cellular proliferation. | Inferred from gene function; no direct clinical evidence yet. |
| Prostate cancer | PAK6 is involved in androgen receptor signaling; readthrough may modulate PAK6 activity or expression, impacting tumor progression. | Inferred from PAK6 function; no direct clinical evidence. |
| Mitotic checkpoint defects | BUB1B is a key mitotic checkpoint protein; readthrough may interfere with BUB1B function, leading to aneuploidy. | Inferred from BUB1B function; no direct clinical evidence. |
Expression Profile
Tissue Expression
| Tissue | nTPM | level |
|---|---|---|
| Testis | Not available | Low expression (based on GTEx data for BUB1B and PAK6) |
| Bone Marrow | Not available | Moderate expression (based on BUB1B) |
| Brain | Not available | Low expression (based on PAK6) |
| Prostate | Not available | Moderate expression (based on PAK6) |
Cell Line Expression
| Cell Line | nTPM | Notes |
|---|---|---|
| HeLa | Not available | Cancer cell line; BUB1B and PAK6 expressed, readthrough may be present |
| MCF7 | Not available | Breast cancer; PAK6 expressed, readthrough possible |
| LNCaP | Not available | Prostate cancer; PAK6 highly expressed, readthrough may be relevant |
Data source:Human Protein Atlas(proteinatlas.org)
Mutations & Variants
Hotspot Mutations
| Variant | Type | Frequency | Functional Description |
|---|---|---|---|
| No specific variants curated | Not applicable | Not applicable | No known disease-associated mutations in the readthrough region; variants in BUB1B or PAK6 may affect readthrough formation. |
Mutation functional classification
Loss of Function (LOF)
Not applicable; no protein product.
Gain of Function (GOF)
Not applicable; no protein product.
Dominant Negative (DN)
Not applicable; no protein product.
View complete mutation data:
Gene Ontology (GO)
| • GO:0005515 protein binding | • GO:0004672 protein kinase activity |
| • GO:0007059 chromosome segregation | • GO:0007094 mitotic spindle assembly checkpoint |
| • GO:0006468 protein phosphorylation | • GO:0005737 cytoplasm |
| • GO:0005634 nucleus |
Pathways
• Cell cycle
• mitotic
• Signaling by Rho GTPases
• Androgen receptor signaling
• p53 pathway
Protein Summary
The BUB1B-PAK6 readthrough gene is predicted to produce a transcript that is a candidate for nonsense-mediated decay, meaning it likely does not yield a functional protein. Instead, the readthrough may serve as a regulatory RNA, potentially influencing the expression of the parental genes BUB1B and PAK6. If translated under certain conditions, the resulting fusion protein would contain an N-terminal portion from BUB1B (including the kinase domain) and a C-terminal portion from PAK6 (also a kinase), potentially creating a chimeric kinase with altered regulation. However, due to NMD, such translation is unlikely under normal conditions. The readthrough may also produce antisense transcripts or affect chromatin structure, adding regulatory complexity.
Related Services
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| BUB1B-PAK6 Knockout HEK293 Cell Line | EDJ-KQ1241 | Human | 106821730 | Details Get a Quote |
| BUB1B-PAK6 Knockout A-549 Cell Line | EDJ-KQ20596 | Human | 106821730 | Details Get a Quote |
| BUB1B-PAK6 Knockout HCT 116 Cell Line | EDJ-KQ20597 | Human | 106821730 | Details Get a Quote |
| BUB1B-PAK6 Knockout HeLa Cell Line | EDJ-KQ20598 | Human | 106821730 | Details Get a Quote |
Displaying Records 1 To 4 Of 4 Records